Rigel Pharmaceuticals | RIGL - Market Capitalization


Rigel Pharmaceuticals reported $5.09B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Celldex Therapeutics USD 2.21B 99M May/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Halozyme Therapeutics USD 8.56B 905M May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
MacroGenics USD 102M 4M Dec/2025
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Pfizer USD 147.4B 6.42B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Veracyte USD 2.59B 16M May/2026